A Randomized, Double-Blinded, Multi-center, Phase 3 Study to Evaluate Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Ezetimibe/rosuvastatin (Primary) ; HGP 1910 (Primary) ; HGP 1909; HGP 1911
- Indications Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Hanmi Pharmaceutical
Most Recent Events
- 04 Mar 2021 Status changed from active, no longer recruiting to completed.
- 10 Dec 2020 New trial record